215 related articles for article (PubMed ID: 8578842)
1. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.
Ott G; Barchfeld GL; Van Nest G
Vaccine; 1995 Nov; 13(16):1557-62. PubMed ID: 8578842
[TBL] [Abstract][Full Text] [Related]
2. A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation.
Deng J; Cai W; Jin F
Int J Pharm; 2014 Jul; 468(1-2):187-95. PubMed ID: 24704309
[TBL] [Abstract][Full Text] [Related]
3. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.
Valensi JP; Carlson JR; Van Nest GA
J Immunol; 1994 Nov; 153(9):4029-39. PubMed ID: 7930610
[TBL] [Abstract][Full Text] [Related]
4. Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant.
Keitel W; Couch R; Bond N; Adair S; Van Nest G; Dekker C
Vaccine; 1993; 11(9):909-13. PubMed ID: 8212835
[TBL] [Abstract][Full Text] [Related]
5. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect.
Calabro S; Tritto E; Pezzotti A; Taccone M; Muzzi A; Bertholet S; De Gregorio E; O'Hagan DT; Baudner B; Seubert A
Vaccine; 2013 Jul; 31(33):3363-9. PubMed ID: 23684834
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice.
Zhang J; Miao J; Han X; Lu Y; Deng B; Lv F; Zhao Y; Ding C; Hou J
BMC Vet Res; 2018 Dec; 14(1):415. PubMed ID: 30577861
[TBL] [Abstract][Full Text] [Related]
7. The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine.
Burke RL; Goldbeck C; Ng P; Stanberry L; Ott G; Van Nest G
J Infect Dis; 1994 Nov; 170(5):1110-9. PubMed ID: 7963702
[TBL] [Abstract][Full Text] [Related]
8. MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice.
Higgins DA; Carlson JR; Van Nest G
Vaccine; 1996 Apr; 14(6):478-84. PubMed ID: 8782343
[TBL] [Abstract][Full Text] [Related]
9. An alternative renewable source of squalene for use in emulsion adjuvants.
Brito LA; Chan M; Baudner B; Gallorini S; Santos G; O'Hagan DT; Singh M
Vaccine; 2011 Aug; 29(37):6262-8. PubMed ID: 21723355
[TBL] [Abstract][Full Text] [Related]
10. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
Sanchez-Pescador L; Burke RL; Ott G; Van Nest G
J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
[TBL] [Abstract][Full Text] [Related]
12. Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.
Fox CB; Barnes V L; Evers T; Chesko JD; Vedvick TS; Coler RN; Reed SG; Baldwin SL
Influenza Other Respir Viruses; 2013 Sep; 7(5):815-26. PubMed ID: 23122325
[TBL] [Abstract][Full Text] [Related]
13. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
Carelli C; Audibert F; Chedid L
Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.
Fox CB; Baldwin SL; Duthie MS; Reed SG; Vedvick TS
AAPS PharmSciTech; 2012 Jun; 13(2):498-506. PubMed ID: 22415641
[TBL] [Abstract][Full Text] [Related]
15. [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
Audibert F; Przewlocki G; Lefrancier P; Choay J; Chedid L
C R Seances Acad Sci III; 1982 Nov; 295(10):611-4. PubMed ID: 6218866
[TBL] [Abstract][Full Text] [Related]
16. Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene.
Del Giudice G; Fragapane E; Bugarini R; Hora M; Henriksson T; Palla E; O'hagan D; Donnelly J; Rappuoli R; Podda A
Clin Vaccine Immunol; 2006 Sep; 13(9):1010-3. PubMed ID: 16960112
[TBL] [Abstract][Full Text] [Related]
17. The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice.
Cataldo DM; Van Nest G
Vaccine; 1997 Nov; 15(16):1710-5. PubMed ID: 9364672
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of humoral immune responses against viral vaccines by a non-pyrogenic 6-O-acylmuramyldipeptide and synthetic low toxicity analogues of lipid A.
Tsujimoto M; Kotani S; Okunaga T; Kubo T; Takada H; Kubo T; Shiba T; Kusumoto S; Takahashi T; Goto Y
Vaccine; 1989 Feb; 7(1):39-48. PubMed ID: 2718605
[TBL] [Abstract][Full Text] [Related]
19. The development of self-emulsifying oil-in-water emulsion adjuvant and an evaluation of the impact of droplet size on performance.
Shah RR; Dodd S; Schaefer M; Ugozzoli M; Singh M; Otten GR; Amiji MM; O'Hagan DT; Brito LA
J Pharm Sci; 2015 Apr; 104(4):1352-61. PubMed ID: 25600347
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of the immune response to influenza virus subunit vaccines.
Webster RG; Glezen WP; Hannoun C; Laver WG
J Immunol; 1977 Dec; 119(6):2073-7. PubMed ID: 915292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
